Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Hi Hangon,

Just got back from hol's so a bit out of touch, no idea as to Deltex future and I doubt if anyone has.

Results.

When I started to read the contents I thought looks good, what's not to like, then I reached the statement 'overall surgical probe sales down 3%' and it was the word overall that bothered me.

Then I got to the 'Circa 20 new enquiries from potential large accounts' and with
operating losses about the same I came to the conclusion that if and it's a big if, at least 50% of those enquiries result in contracts then Deltex will be over the, will they won't they make it line.
The problem as always with Deltex is what do they mean by large accounts and until we start to see actual figures from one or two of these accounts then I am still neither pro or con.

I am not going to comment on the contents of the evidence update RNS as no matter how good previous results have been, it tends not to result in notable contracts which is all that really matters.

Director/PDMR Shareholding


8 October 2014 - Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), announces that on 7 October 2014 Mr Tim Irish, non-executive Director informed the Company of the purchase of 848,484 Ordinary Shares at a price of 8.25 pence per Ordinary Share through his Self Invested Personal Pension.

As a result Mr Irish's shareholding totals 1,348,484 ordinary shares (representing 0.63 per cent. of the issued share capital of Deltex Medical).

RNS,

2,200,000 shares bought, first time for a long while that an institution has bought into Deltex.

Do they know something we don't!

Another study shows how the CardioQ could save lives and time spent in hospital (must be almost 90 it total now)and yet again such a report has no effect on the sp which has been on a downward trend for so long now it's getting monotonous.

It only strengthens the fact that as there have been so many such reports that have no lasting effect on the sp, that contracts and only contracts will save this company.

If the CardioQ had been rubbished in a few or more medical studies then I could accept Deltex's position but as we all know that the CardioQ does work for both the benefits of the patients directly and indirectly by saving medical establishments money it makes me both angry at the lack of take up and the continuing sp decline.

Its difficult to feel positive about a product when it is so obvious that potential end users don't.

I do get fed up of posting negative posts (the RNS should be a pre-cursor to a positive post), but facts have to be faced.

We desperately need some news.

If the sp continues on it' downward direction, there soon won't be many investors to inform.

Speak to us now for gawds sake,

Month after month and still no sp mending news.

Is anyone at home or have they all locked up and gone home, just how much longer are we expected to believe?

Another company I am invested in changed it's CEO a week ago today, and this morning an RNS was released stating several things had been accelerated by quite a considerable time line.

The new CEO has a reputation for direct action and was bought in because of pressure by the big institutional investors.

Many investors in this company had commented for some time that things appeared to be going too slowly and that someone needed to get a grip and take a few more risks.

This brings me to Deltex
It makes me wonder again if Ewan Phillips is being too cautious and a too much Mr nice guy.

As said before, if the present action plan is not getting anywhere (we know things are progressing slowly) then surely it's time to look at a plan B.

Appreciate that I am probably talking to myself, but From a RNS last April,


The NHSE standard contract technical guidance for 2014/15 mandates that, by March 2015, all hospitals should "demonstrate to commissioners that trajectories for the intra-operative fluid management (IOFM) technologies are in place which are consistent with National Technology Adoption Centre (NTAC - now the Health Technology Adoption Programme) guidance".1,2.

It goes on to say that the guide for implementation of IOFM was published in 2013.

With just over 2 months to go I have seen very little progress regarding the above. I wonder just what action will be taken by the NHSE standard commissioners if insufficient evidence of take up is shown, they will probably just keep taking their no doubt hefty salaries and do nothing .

Whilst accepting that the main markets are the USA and a few other countries and that the NHS is almost a none starter (OK they have started, but appear to have stopped), is anyone else becoming despondent on these other markets as nothing appears to be moving.

I remember several posters including myself stating in 2012 that that year was make or break for Deltex, same was said in 2013 and again this year, so as we head for yet another year end passing with little progress, I wonder what 2015 will bring, more of the same, a takeover or will things start to finally pay off for all our patience.

Personally I have no idea which option is the most likely although on past form I feel that more of the same is probable.

It must be 2 years or so since I sold my holding greekman, I missed the rise to around 30p but I'm glad I exited. One day your faith in DEMG may hopefully bring you some reward, good luck.
2517

Hi George,

I sold right down around the same time as you (wish like you I had sold out completely), left me with a token gesture of around 4,000 shares.

Cheers and Merry Xmas.

What will 2015 bring.

RNS,

Looks like 2014 will as the last paragraph states will be flat, but at least there is more movement by the NHS and that small tender from Canada (if we get it) could be the start of something big.

So it looks like 2015 will be Deltex's year and it better be otherwise I and many others still left will be out.
They can't have too many lives left!


NHS Supply Chain has ordered 60 CardioQ-ODM+ monitors to support their 2015 NHS business plan.

At this stage the Company is actively pursuing potential orders from individual NHS Trusts with a collective value in excess of £1 million. If all closed out successfully, these would mean approximately flat UK sales when compared to the 2013 financial year end. In addition, the Company is pursuing a tender worth up to £0.3m from a hospital system in Canada which was expected to be announced earlier in December but is now not expected to be awarded until 2015.

31% down on opening, can only be for one of two reasons,

1 The market knows something we don't, 2 price manipulation or both.

It also looks like as often been said people want nothing short of a gigantic contract.

Could of course be the mm's wanting shares for a big order, well we have to dream don't we, it is Xmas after all.

Well Hope ,or (the inversion of?) Hype - that NHS Order is both good and bad - Bad that it's accompanying a statement that overall Orders are below Market expectations ( so they might have told us earlier!)..... and Good in that it is quite large compared with zippo - and the NHS is a hard "nut" to crack . . . .

What do others think?

Agree Hangon, that's just how I look at it.

No matter what views have been expressed here, the fact that no one can get away from is that Deltex shares have been a dog of a share during 2014, they are the worse performing share of my portfolio.

All we can hope for is a better 2015!

They were tipped as a 'good entry price' @9p in september shares mag.
2517

Hi George,

There was article in the Telegraph a few days ago which showed that only around 3% of professional tipsters portfolio's beat FTSE trackers. Bearing in mind that some people pay big money for pre media release priority tips, it goes to show that often you could beat these tipsters by sticking a pin in the shares list.

A few years ago I was contacted by a financial adviser just after retirement which was arranged by my previous employers, he offered to sort out a new mortgage as my fix was ending, although this was free, he would normally charge around £150 (this was in 2003). I contacted him a week later quoting a mortgage that I had found myself, he came back a few hours later stating he could not beat the deal I had found.

Anyway, that's my last moan re tipsters for 2014, hope you have a good 2015.

Plenty of room for improvement.

Of all the AIM shares quoted in The Telegraph, Deltex are the second highest looser for 2014.

We all accept that the CardioQ saves lives/money and that for finance purposes its a no brainer, the problem is the total lack of commercial sense when it comes to NHS Trusts.

I can give three examples of where my local NHS Trust (Hull) wasted many thousands of £s.

Several years ago almost every lampost on the approach to my local hospital displayed a placard with the picture of a medical person with very enlarged ears, with the caption 'We are listening'.

Around the same time a large part of A and E was redesigned with several paintings being purchased. many local artists would have been happy to donate paintings for display tried up with an advert to sell.

And the most money wasting project of the three, was a purchase of a yacht for £400,00 plus crew and other running costs, that would be used to help homeless teenagers to make better lifestile choices (I kid you not, see link), and this is still ongoing.

No doubt other trusts are wasting money on similar projects.

All goes to prove what these NHS Trust job-worthies waste money on.



http://www.telegraph.co.uk/health/3195750/NHS-trust-to-buy-400000-yacht.html